Showing results (71-80 of 81) with videos related to
Sort By:
Pageof 9
JAMA Cardiology|May 23, 2019
Effect of the PCSK9 Inhibitor Evolocumab on Total Cardiovascular Events in Patients With Cardiovascular Disease: A Prespecified Analysis From the FOURIER TrialSabina A Murphy, Terje R Pedersen, Zbigniew A Gaciong, et al.The Lancet. Diabetes & Endocrinology|September 21, 2017
Cardiovascular safety and efficacy of the PCSK9 inhibitor evolocumab in patients with and without diabetes and the effect of evolocumab on glycaemia and risk of new-onset diabetes: a prespecified analysis of the FOURIER randomised controlled trialMarc S Sabatine, Lawrence A Leiter, Stephen D Wiviott, et al.Circulation Journal : Official Journal of the Japanese Circulation Society|May 13, 2021
Efficacy and Safety of Long-Term Evolocumab Use Among Asian Subjects - A Subgroup Analysis of the Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk (FOURIER) TrialAnthony C Keech, Kazuma Oyama, Peter S Sever, et al.Lancet (London, England)|September 2, 2017
Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trialRobert P Giugliano, Terje R Pedersen, Jeong-Gun Park, et al.Circulation|December 28, 2018
Lipoprotein(a), PCSK9 Inhibition, and Cardiovascular RiskMichelle L O'Donoghue, Sergio Fazio, Robert P Giugliano, et al.Current Nutrition Reports|February 15, 2022
Sodium and Health: Old Myths and a Controversy Based on DenialFrancesco P Cappuccio, Norm R C Campbell, Feng J He, et al.European Heart Journal|March 25, 2015
The effect of statin therapy on heart failure events: a collaborative meta-analysis of unpublished data from major randomized trialsDavid Preiss, Ross T Campbell, Heather M Murray, et al.Lancet (London, England)|September 29, 2014
HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trialsDaniel I Swerdlow, David Preiss, Karoline B Kuchenbaecker, et al.Nature Genetics|November 24, 2020
Discovery of rare variants associated with blood pressure regulation through meta-analysis of 1.3 million individualsPraveen Surendran, Elena V Feofanova, Najim Lahrouchi, et al.Plos One|June 19, 2018
Novel genetic associations for blood pressure identified via gene-alcohol interaction in up to 570K individuals across multiple ancestriesMary F Feitosa, Aldi T Kraja, Daniel I Chasman, et al.Pageof 9